Lazarus  Krikorian net worth and biography

Lazarus Krikorian Biography and Net Worth

CAO of Cencora
Lazarus Krikorian is Senior Vice President and Corporate Controller of AmerisourceBergen. Prior to being named to his current role in 2012, he was Vice President and Assistant Corporate Controller since joining the Company in 2002.

Prior to joining AmerisourceBergen, he held other financial management positions, including Senior Assurance Manager at KPMG LLP, where he spent a decade. He holds a Bachelor of Science in the dual major of Accounting and Finance from Drexel University.

What is Lazarus Krikorian's net worth?

The estimated net worth of Lazarus Krikorian is at least $4.83 million as of December 1st, 2023. Mr. Krikorian owns 19,876 shares of Cencora stock worth more than $4,833,843 as of November 21st. This net worth approximation does not reflect any other investments that Mr. Krikorian may own. Learn More about Lazarus Krikorian's net worth.

How old is Lazarus Krikorian?

Mr. Krikorian is currently 59 years old. There are 7 older executives and no younger executives at Cencora. The oldest executive at Cencora is Ms. Gina K. Clark, Executive VP and Chief Communications & Administration Officer, who is 67 years old. Learn More on Lazarus Krikorian's age.

How do I contact Lazarus Krikorian?

The corporate mailing address for Mr. Krikorian and other Cencora executives is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. Cencora can also be reached via phone at (610) 727-7000 and via email at [email protected]. Learn More on Lazarus Krikorian's contact information.

Has Lazarus Krikorian been buying or selling shares of Cencora?

Lazarus Krikorian has not been actively trading shares of Cencora in the last ninety days. Most recently, Lazarus Krikorian sold 2,000 shares of the business's stock in a transaction on Friday, December 1st. The shares were sold at an average price of $203.60, for a transaction totalling $407,200.00. Following the completion of the sale, the chief accounting officer now directly owns 19,876 shares of the company's stock, valued at $4,046,753.60. Learn More on Lazarus Krikorian's trading history.

Who are Cencora's active insiders?

Cencora's insider roster includes Silvana Battaglia (EVP), Elizabeth Campbell (EVP), John Chou (EVP), Gina Clark (EVP), Gina Clark (EVP), Steven Collis (CEO), Leslie Donato (EVP), Leslie Donato (EVP), Jeffrey Finnin (CFO), Juan Font (SVP), Jane Henney, MD (Director), Mark Jones (CAO), Maile Kaiser (SVP), Michael Koehler (Director), Lazarus Krikorian (CAO), Aleksandra Krusko (SVP), Robert Mauch (EVP), Robert Mauch (COO), Derek McCandless (SVP), Henry McGee, III (Director), Steven Smith (CRO), Paul Szurek (CEO), and Brian Warren (SVP). Learn More on Cencora's active insiders.

Are insiders buying or selling shares of Cencora?

During the last year, Cencora insiders bought shares 1 times. They purchased a total of 500 shares worth more than $109,290.00. During the last year, insiders at the sold shares 15 times. They sold a total of 10,679,455 shares worth more than $2,497,519,666.75. The most recent insider tranaction occured on October, 22nd when Chairman Steven H Collis sold 21,509 shares worth more than $5,071,822.20. Insiders at Cencora own 15.8% of the company. Learn More about insider trades at Cencora.

Information on this page was last updated on 10/22/2024.

Lazarus Krikorian Insider Trading History at Cencora

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/1/2023Sell2,000$203.60$407,200.0019,876View SEC Filing Icon  
2/7/2023Sell5,711$155.82$889,888.0218,732View SEC Filing Icon  
12/21/2022Sell2,218$169.24$375,374.3220,007View SEC Filing Icon  
5/11/2022Sell4,895$160.00$783,200.0014,079View SEC Filing Icon  
2/3/2022Sell11,653$138.14$1,609,745.42View SEC Filing Icon  
6/8/2020Sell19,386$99.90$1,936,661.40
11/28/2018Sell20,276$90.37$1,832,342.1228,419View SEC Filing Icon  
11/30/2017Sell16,427$84.86$1,393,995.2223,360View SEC Filing Icon  
3/3/2017Sell9,958$91.83$914,443.1415,743View SEC Filing Icon  
5/8/2015Sell21,802$115.35$2,514,860.70View SEC Filing Icon  
2/10/2015Sell18,000$96.03$1,728,540.00View SEC Filing Icon  
See Full Table

Lazarus Krikorian Buying and Selling Activity at Cencora

This chart shows Lazarus Krikorian's buying and selling at Cencora by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cencora Company Overview

Cencora logo
Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Read More

Today's Range

Now: $243.20
Low: $240.53
High: $243.64

50 Day Range

MA: $232.82
Low: $219.50
High: $249.95

2 Week Range

Now: $243.20
Low: $195.83
High: $251.56

Volume

753,912 shs

Average Volume

1,403,907 shs

Market Capitalization

$47.92 billion

P/E Ratio

32.38

Dividend Yield

0.92%

Beta

0.44